- Trials with a EudraCT protocol (91)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (56)
91 result(s) found for: AMC.
Displaying page 1 of 5.
EudraCT Number: 2005-000974-29 | Sponsor Protocol Number: TH0501 | Start Date*: 2005-04-01 |
Sponsor Name:Boots Healthcare International Limited | ||
Full Title: An open label, oral bioavailability study to determine the levels of Amylmetacresol BP (AMC) and 2,4-dichlorobenzyl alcohol (DCBA) in the saliva of healthy volunteers after a single oral dose of S... | ||
Medical condition: AMC and DCBA are indicated for the symptomatic relief of mouth and throat infections. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-002269-14 | Sponsor Protocol Number: NL80263.018.21 | Start Date*: 2022-08-11 |
Sponsor Name:AMC, Cardiovascular Sciences | ||
Full Title: Dotatate to locate coronary plaques at high-risk of myocardial infarction | ||
Medical condition: Inflammatory atherosclerosis of the coronary arteries. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003739-40 | Sponsor Protocol Number: 59153 | Start Date*: 2017-03-06 |
Sponsor Name:AMC Amsterdam | ||
Full Title: The effect of Iberogast on heartburn in patients with dyspepsia | ||
Medical condition: Dyspepsia (according to the Rome III criteria) with heartburn. Upper gastro-intestinal causes of the complaints excluded via gastroscopy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000404-35 | Sponsor Protocol Number: 80519 | Start Date*: 2022-07-26 |
Sponsor Name:AMC, Cardiovascular Sciences | ||
Full Title: Does the hematopoietic stem cell govern residual inflammatory cardiovascular risk in type 2 diabetes? | ||
Medical condition: Inflammation in patients with type 2 diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001240-21 | Sponsor Protocol Number: 69024 | Start Date*: 2019-07-03 |
Sponsor Name:Amsterdam UMC, location AMC | ||
Full Title: Exposure to orally administered antibiotics during the initial phase of infection in non-critically ill, febrile patients | ||
Medical condition: Exposure to oral antibiotics will be investigated in infectious patients when they are febrile compared to when they are afebrile. The infection itself is unspecified. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000543-27 | Sponsor Protocol Number: 19852012 | Start Date*: 2012-04-23 |
Sponsor Name:AMC | ||
Full Title: A Proof of Concept Study to Determine the Local Delivery and Efficacy of Intravenously Injected PEG-Liposomal Prednisolone Sodium Phosphate (Nanocort®) in Atherosclerotic Tissue in Subjects with Pe... | ||
Medical condition: Vessel wall inflammation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000449-15 | Sponsor Protocol Number: DIONYSIUS | Start Date*: 2020-12-11 |
Sponsor Name:Amsterdam University Medical Centers, location AMC | ||
Full Title: Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently? | ||
Medical condition: Ischemic diabetic foot ulcers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002860-19 | Sponsor Protocol Number: 2012 | Start Date*: 2014-01-07 |
Sponsor Name:AMC | ||
Full Title: The risk of cardiovascular disease in Ankylosing Spondylitis; A Single Center Cross-Sectional Study Evaluating The Association Between Inflammation In Ankylosing Spondylitis And Vascular Inflammati... | ||
Medical condition: Ankylosing Spondylitis Atherosclerotic cardiovascular disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003168-28 | Sponsor Protocol Number: 77458 | Start Date*: 2022-06-28 |
Sponsor Name:Academic Medical Center (AMC), department of Internal Medicine | ||
Full Title: Impact of Triglyceride-Lowering on Inflammatory Activity in Patients with Hypertriglyceridemia | ||
Medical condition: - Hypertriglyceridemia - Inflammation - Lipoproteins | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-004078-53 | Sponsor Protocol Number: 83403 | Start Date*: 2023-08-22 |
Sponsor Name:Academic Medical Center (AMC), department of Internal Medicine | ||
Full Title: Specifying the anti-inflammatory effects of ziltivekimab with diverse imaging modalities and in-depth cellular phenotyping | ||
Medical condition: - Plaque characteristics - Systemic inflammation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002667-42 | Sponsor Protocol Number: ABR53999 | Start Date*: 2015-09-09 |
Sponsor Name:AMC | ||
Full Title: Sedation with propofol TCI during ERCP: Is the combination with esketamine more effective and safer than with alfentanil (SPEKA): A randomized controlled multicentre trial | ||
Medical condition: Patients undergoing ERCPs under propofol sedation combined with ketamine or alfentanil given by trained anesthesia nurse. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004995-17 | Sponsor Protocol Number: NL7507301820 | Start Date*: 2021-03-11 |
Sponsor Name:AMsterdam UMC-AMC | ||
Full Title: Low dose iron chelation as TReatment of Oxidative stress in Sickle cell disease; TROS study | ||
Medical condition: Sickle cell disease (an hereditary hemoglobinopathy) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-002179-12 | Sponsor Protocol Number: PRILODE50-FUSION | Start Date*: 2022-09-16 | |||||||||||
Sponsor Name:Matilde Zaballos | |||||||||||||
Full Title: Determination of the effective dose 50 of intrathecal hyperbaric prilocaine required for the transrectal ultrasound guidance fusion-targeted prostate biopsy in ambulatory surgery | |||||||||||||
Medical condition: anaesthesia for prostate fusion biopsy in outpatient surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-005021-79 | Sponsor Protocol Number: 72541 | Start Date*: 2020-03-10 |
Sponsor Name:Amsterdam UMC - location Academic Medical Centre (AMC) | ||
Full Title: Revised dosing recommendations of ciprofloxacin for patients with impaired renal function: a bioequivalence study. | ||
Medical condition: Ciprofloxacin exposure in patients treated for a bacterial infection. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002864-30 | Sponsor Protocol Number: NL73019.018.20 | Start Date*: 2020-07-29 |
Sponsor Name:Amsterdam UMC, location AMC | ||
Full Title: Sulodexide for chronic heart failure: a proof of concept, randomized, placebo-controlled study | ||
Medical condition: Chronic heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005059-67 | Sponsor Protocol Number: TH0809 | Start Date*: 2008-11-04 | |||||||||||
Sponsor Name:Reckitt Benckiser Healthcare UK Ltd | |||||||||||||
Full Title: A multi-centre, randomised, double blind, placebo-controlled, parallel group, single dose, pilot study of the efficacy of 0.6 mg Amylmetacresol BP (AMC) and 1.2mg 2,4-Dichlorobenzyl alcohol (DCBA) ... | |||||||||||||
Medical condition: Sore throat | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003594-17 | Sponsor Protocol Number: NL59077.018.16 | Start Date*: 2018-05-28 | |||||||||||
Sponsor Name:AMC | |||||||||||||
Full Title: Effects of a single denosumab injection on reduction of total contact cast treatment and consolidation of bonefractures caused by acute Charcotfoot in patients with diabetes mellitus (CHARCOT st... | |||||||||||||
Medical condition: charcot foot | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003594-95 | Sponsor Protocol Number: MTXSB2018 | Start Date*: 2019-04-30 | ||||||||||||||||
Sponsor Name:Amsterdam UMC location AMC | ||||||||||||||||||
Full Title: Methotrexate to suppress immunogenicity to anti-tumor necrosis factor therapy in IBD patients with loss of response | ||||||||||||||||||
Medical condition: Inflammatory bowel disease: Crohn's disease and Ulcerative colitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004206-19 | Sponsor Protocol Number: ABR36861 | Start Date*: 2012-01-12 |
Sponsor Name:AMC | ||
Full Title: Patient and Endoscopist Satisfaction with DEXmedetomidine versus Propofol/Alfentanil sedation during oesophagus interventions (PESDEX). | ||
Medical condition: Patients undergoing therapeutically esophageal interventions under sedation (dexmedetomidine or propofol/alfentanil) given by trained anesthesia nurse. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-003245-29 | Sponsor Protocol Number: SA652013 | Start Date*: 2016-12-19 |
Sponsor Name:Amsterdam AMC, locatie AMC | ||
Full Title: Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after Roux-en-Y gastric bypass and Sleeve Gastrectomy | ||
Medical condition: Prevention of symptomatic gallstone disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
